Package 24979-102-07

{"route": ["ORAL"], "spl_id": "98bee4c5-7da0-4607-ab0a-b2af714d41d5", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["cdf6e6d9-28e4-48a8-a5ae-7549b3e1402a"], "manufacturer_name": ["TWi Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24979-102-02)", "package_ndc": "24979-102-02", "marketing_start_date": "20180830"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24979-102-06)", "package_ndc": "24979-102-06", "marketing_start_date": "20180830"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24979-102-07)", "package_ndc": "24979-102-07", "marketing_start_date": "20180830"}], "brand_name": "Bupropion Hydrochloride (XL)", "product_id": "24979-102_98bee4c5-7da0-4607-ab0a-b2af714d41d5", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "24979-102", "generic_name": "bupropion hydrochloride", "labeler_name": "TWi Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "(XL)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA210081", "marketing_category": "ANDA", "marketing_start_date": "20180830", "listing_expiration_date": "20261231"}